I picked this up off a blog specializing in health care wonkery. Read the whole damn thing. It's great.
Check it out..
Here's a snippet:
That's an interesting point and it makes sense to me. Curing cancer has no real profit to it. Once the drug is patented and the medicine is distributed, the market for the drug dries up. Why? Because the market share -- people with cancer -- goes away because the disease is cured. Now, compare that idea to all the other drugs you see advertised on TV. They all treat a chronic problem. The problem isn't even cured. The consumer has to keep on buying the medicine, guaranteeing more sales. It's a perfect scheme.
Anyway, it's a pretty good article and it dispels some myths about Big Pharma's ability to innovate. Like we need 18,003 pills for Erectile Dysfunction.
Check it out..
Here's a snippet:
Quote:
|
Originally Posted by GoozeNews
First, on costs. Why does industry spend $20 billion a year on clinical trials? Is it because the cost of trials has skyrocketed? Or is it because the new drugs that industry is bringing to market are such minor innovations or no innovation at all compared to previous drugs that it takes trials with literally thousands of people in them to prove something works.
|
Anyway, it's a pretty good article and it dispels some myths about Big Pharma's ability to innovate. Like we need 18,003 pills for Erectile Dysfunction.
